Document is current

Any future updates will be listed below

Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease

Crossref DOI link: https://doi.org/10.1007/978-3-030-60204-8_14

Published Online: 2021-01-09

Published Print: 2020

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark